- Home
- ALGS vs CULP Comparison
ALGS vs CULP Comparison
Compare ALGS & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- CULP
- Stock Information
- Founded
- ALGS 2018
- CULP 1972
- Country
- ALGS United States
- CULP United States
- Employees
- ALGS N/A
- CULP N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- CULP Textiles
- Sector
- ALGS Health Care
- CULP Consumer Discretionary
- Exchange
- ALGS Nasdaq
- CULP Nasdaq
- Market Cap
- ALGS 64.8M
- CULP 52.7M
- IPO Year
- ALGS 2020
- CULP N/A
- Fundamental
- Price
- ALGS $7.21
- CULP $4.00
- Analyst Decision
- ALGS Strong Buy
- CULP
- Analyst Count
- ALGS 2
- CULP 0
- Target Price
- ALGS $60.00
- CULP N/A
- AVG Volume (30 Days)
- ALGS 99.6K
- CULP 16.0K
- Earning Date
- ALGS 11-06-2025
- CULP 12-03-2025
- Dividend Yield
- ALGS N/A
- CULP N/A
- EPS Growth
- ALGS N/A
- CULP N/A
- EPS
- ALGS N/A
- CULP N/A
- Revenue
- ALGS $3,174,000.00
- CULP $207,391,000.00
- Revenue This Year
- ALGS N/A
- CULP $1.93
- Revenue Next Year
- ALGS N/A
- CULP $2.77
- P/E Ratio
- ALGS N/A
- CULP N/A
- Revenue Growth
- ALGS N/A
- CULP N/A
- 52 Week Low
- ALGS $3.76
- CULP $3.42
- 52 Week High
- ALGS $46.80
- CULP $5.94
- Technical
- Relative Strength Index (RSI)
- ALGS 28.33
- CULP 36.19
- Support Level
- ALGS $9.25
- CULP $3.95
- Resistance Level
- ALGS $8.76
- CULP $4.25
- Average True Range (ATR)
- ALGS 0.77
- CULP 0.11
- MACD
- ALGS -0.30
- CULP -0.02
- Stochastic Oscillator
- ALGS 2.68
- CULP 11.13
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.